StemCell Therapy

1. Dykewicz CA, Jaffe HW, Kaplan JE, et al. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000;49:1125. CE17.

72. Hakim FT, Mackall CL. The immune system: effector and target of GVHD. In: Ferrara JLM, Deeg HJ, Burakoff SJ, editors. Graft-vs-Host Disease. New York: Marcel Dekker; 1997. pp. 257289.

76. AABB. Standards for cellular therapy product services. Bethesda, MD: AABB; 2007.

77. FACT-JACIE. International standards for cellular therapy product collection, processing, and administration. Omaha: Foundation for the Accreditation of Cellular Therapy; 2006.

78. National Marrow Donor Program. National Marrow Donor Program Standards. 19. Minneapolis: National Marrow Donor Program; 2004.

80. Food and Drug Administration. Guidance for industry: Eligibility determination for donors of human cells, tissues, and cellular- and tissue-based products (HCT/Ps) Washington, DC: US Department of Health and Human Services; 2007.

81. European Commission. Commission Directive 2004/23/EC. Official Journal of the European Union. 2004;L 102:4858.

82. European Commission. Commission Directive 2006/17/EC. Official Journal of the European Union. 2006;L 38:4052.

83. US National Archives and Records Administration. 21 CFR, Part 1271, Subpart C -- Donor Eligibility. Washington, DC: GPO; 2004.

115. AABB. Standards for Blood Banks and Transfusion Services. Bethesda, Maryland: AABB; 2008.

125. National Marrow Donor Program. Donor health history screening questionnaire. Minneapolis: National Marrow Donor Program; 2007.

127. Reich-Slotky R, Semidei-Pomales M, Schwartz J. Microbial pathogens of hematopoietic stem cells - screening and testing for infectious diseases. Rev Med Microbiol. 2007;18:1727.

142. US National Archives and Records Administration. 21 CFR, Part 1271, Subpart D -- Good Tissue Practice. Washington, DC: GPO; 2004.

143. NetCord-FACT. International standards for cord blood collection, processing, testing, banking, selection, and release. Omaha: Foundation for the Accreditation of Cellular Therapy; 2006.

148. Bucaneve G, Castagnola E, Viscoli C, Leibovici L, Menichetti F. Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients. Eur J Cancer. 2007;(suppl 5):512.

153. The European Antimicrobial Resistance Surveillance System (EARSS) Annual Report 2006. 2006:2008.

170. Bowden RA, Myers JD. Infection complicating bone marrow transplantation. In: Rubin RHYL, editor. Clinical Approach to Infection in the Compromised Host. New York, NY: Plenum Medical Book Co; 1994. pp. 60128.

192. American Academy of Pediatrics/Committee on Infectious Diseases. Pneumococcal infections. In: Pickering LK, editor. 2006 Red Book: Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006. pp. 525537.

195. Cordonnier C, Labopin MVC, et al. Influence of immunisation timing on the response to conjugate-pneumococcal vaccine after allogeneic stem cell transplant: final results of the EBMT IDWP01 Trial. Bone Marrow Transplant. 2008;45

204. American Academy of Pediatrics. Haemophilus influenzae infections. In: LK P, editor. 2006 Red Book: Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006. pp. 310318.

208. American Academy of Pediatrics/Committee on Infectious Diseases. Pertussis. In: Pickering LK, editor. 2006 Red Book: Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p. 502.

227. Mendez JC, Sia IG, Paya CV. Human cytomegalovirus. In: Lennette EHST, editor. Laboratory Diagnosis of Viral Infections. New York, NY: Marcel Decker, Inc; 1999. pp. 36172.

235. Volin L, Barkholt L, Nihtinen A, et al. An open-label randomised study of oral valganciclovir versus intravenous ganciclovir for pre-emptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation [abstract] Bone Marrow Transplant. 2008;41 (Suppl 1):47.

294. Merck. Varivax: Varicella Vaccine Live. 2008.

295. Merck. Zostavax: Zoster Vaccine Live. 2007.

308. American Academy of Pediatrics. Influenza. In: LK P, editor. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006. pp. 401411.

319. American Academy of Pediatrics. Respiratory Syncytial Virus. In: LK P, editor. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006. pp. 560566.

324. American Academy of Pediatrics. Parainfluenza Viral Infections. In: LK P, editor. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006. pp. 479481.

325. LK P, editor. American Academy of Pediatrics. Adenovirus Infections. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006. pp. 202204.

326. Horwitz MS. Adenoviruses. In: Knipe DMHPM, editor. Fields Virology. Philadelphia: Lippincott, Williams and Wilkins; 2001. pp. 23012326.

349. Egli A, Infanti L, Stebler C, Bodaghi S, Gosert R, Hirsch HH. Polyomavirus BK (BKV) and JC (JCV) Replication in Plasma and Urine in Healthy Blood Donors (Abstract #1058) Am J Transplant. 2008;8 (S2):460.

411. Gupta V, Tomblyn M, Pederson T, et al. Allogeneic hematopoietic stem cell transplantation in HIV-positive patients with malignant and non-malignant disorders: A report from the center for international blood and marrow transplant research (CIBMTR) Biol Blood Marrow Transplant. 2007;13:56.

430. Wingard JR, Carter SL, Walsh TJ, et al. Results of a randomized, double-blind trial of fluconazole vs. voriconazole for the prevention of invasive fungal infections in 600 allogeneic blood and marrow transplant patients. Blood. 2007;110:55a.

493. Walter E, Chauncey T, Boeckh M, Hackman B, Kennedy M, Bowden R. PCP prophylaxis after marrow transplantation: efficacy of trimethoprim-sulfamethoxazole (trim-sulfa), role of trim-sulfa desensitization and iv pentamidine [abstract 32] 1993

527. World Health Organization. World Malaria Report 2008. Geneva, Switzerland: World Health Organization; 2008.

532. American Institute of Architects Facility Guidelines Institute, AIA Academy of Architecture for Health, US Dept. of Health & Human Services. Guidelines for Design and Construction of Health Care Facilities. Washington DC: American Institute of Architects Press; 2006.

546. Streifel AJ. Design and maintenance of hospital ventilation systems and the prevention of airborne infections. In: MC, editor. Hospital Epidemiology and Infection Control. Philadelphia: Lippincott, Williams & Wilkins; 2004.

549. Bartley J. Prevention of infections related to construction, renovation, and demolition systems. In: MC, editor. Hospital Epidemiology and Infection Control. Philadelphia: Lippincott, Williams & Wilkins; 2004.

561. Streifel AJ. Aspergillus and construction. In: Kundsin RB, editor. Architectural Design and Indoor Microbial Pollution. New York, N.Y: Oxford University Press; 1988. pp. 198216.

582. National Antimicrobial Information Network. List of EPA registered products.

583. CDC/National Center for Infectious Diseases/Hospital Infections Program. Sterilization or disinfection of medical devices: general purposes. Atlanta, GA: US Department of Health and Human Services, CDC; 2000.

584. Favero M, Bond W. Chapter 24: sterilization, disinfection, and antispsis int he hospital. In: Hauser WJ Jr, Herrman JL, Isenberg HD, Shadomy HJ, editors. Manual of clincial microbiology. Washington DC: American Society for Microbiology; 1991. pp. 183200.

585. Johnson S, Gerding D. Chapter 29: Clostridium difficile. In: Mayhall CG, editor. Hospital Epidemiology and infection control. Philadelphia, PA: Lippincott Williams & Wilkins; 1999. pp. 46776.

587. Centers for Disease Control and Prevention (CDC) Nosocomial outbreak of Rhizopus infections associated with Elastoplast wound dressings-Minnesota. MMWR Morb Mortal Wkly Rep. 1978;27:334.

588. Centers for Disease Control and Prevention (CDC) Follow-up on Rhizopus infections associated with Elastoplast bandages-United States. MMWR Morb Mortal Wkly Rep. 1978;27:2434.

598. Centers for Disease Control and Prevention (CDC) ABCs of safe and healthy child care: an on-line handbook for child care providers. Atlanta, GA: US Department of Health and Human Services, CDC; 2000.

603. Centers for Disease Control and Prevention (CDC) Infection Control Guidance for the Prevention and Control of Influenza in Acute-Care Facilities. Atlanta, GA: Centers for Disease Control and Prevention; 2007.

607. Schubert MM, Peterson DE, Lloid ME. Oral complications. In: Thomas ED, Blume KG, Forman SJ, editors. Hematopoietic Cell Transplantation. Oxford, England: Blackwell Science, Inc; 1999. pp. 75163.

619. Palmore TN, Stock F, White M, et al. An outbreak of nosocomial Legionnaires disease linked to a contaminated hospital water feature. 2008

623. Dutch Workingparty Infection Prevention. Policy for Methicillin-resistant. Staphylococcus aureus. 2005

637. Centers for Disease Control. Vancomycin-Intermediate/Resistant Staphylococcus aureus Laboratory Testing Algorithm. 2006;2009:1.

639. NCCLS. Performance standards for antimicrobial disk susceptibility testing. Fourteenth informational supplement. NCCLS document. 2004:M100514.

695. Centers for Disease Control and Prevention (CDC) Norovirus in Healthcare Facilities Fact Sheet. Atlanta, GA: National Center for Preparedness, Detection, and Control of Infectious Diseases; 2006.

701. Gaynes RP, Horan TC. Surveillance of nosocomial infections. In: CGM, editor. Hospital Epidemiology and Infection Control. Philadelphia, PA: Lippincott Williams & Wilkins; 1999. pp. 1285317.pp. 85

705. Centers for Disease Control and Prevention. Preventing Cryptosporidiosis: A Guide for People with Compromised Immune System. 2005.

739. Clinical Review for STN 125265/0 Rotarix; 2008.

744. ACIP Provisional Recommendations for use of Zoster Vaccine.;2008.

746. Centers for Disease Control and Prevention (CDC) Crypto - Cryptosporidiosis: Prevention--Immunocompromised Persons. 2008. 2008.

760. Centers for Disease Control and Prevention (CDC) Risks from Food and Water (Drinking and Recreational) Atlanta, Georgia: Centers for Disease Control and Prevention; 2008.

762. American Academy of Pediatrics. Cryptosporidiosis. In: Pickering LK, editor. Red Book: 2003 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2003. pp. 123127.

763. American Public Health Association. Control of Communicable Disease Manual. Washington, DC: American Public Health Association; 2004. Cryptosporidiosis; pp. 13841.

768. Handle and Prepare Food Safely. 2008.

770. The Big Thaw - Safe Defrosting Methods for Consumers. 2008.

771. Moe GL. Low-microbial diets for patients with granulocytopenia. In: Bloch AS, editor. Nutrition Management of the Cancer Patient. Rockville, MD: Aspen Publishing, Inc; 1990. pp. 12534.pp. 12

772. Aker SN, Lenssen P. Nutritional support of patients with hematologic malignancies. In: Benz EJ Jr, Cohen JJ, Burie B, editors. Hematology: Basic Principles and Practice. New York, NY: Churchill Livingstone; 2000. pp. 150114.pp. 80

779. Centers for Disease Control and Prevention (CDC) Travelerss Health: Destinations. Atlanta, Georgia: Centers for Disease Control and Prevention; 2007.

784. Centers for Disease Control and Prevention (CDC) Travelers Health: Yellow Book. Atlanta, Georgia: Centers for Disease Control and Prevention; 2008.

785. Centers for Disease Control and Prevention (CDC) Water Treatment Methods. Atlanta, GA: Centers for Disease Control and Prevention;

799. Parkman R, Weinberg K. Immunological reconstitution following hematopoietic stem cell transplantation. In: Blume K, Forman S, Appelbaum F, editors. Thomass Hematopoietic Cell Transplantation. Malden: Blackwell Science; 2003. pp. 853861.

800. Storek J, Witherspoon R. Immunological reconstitution after hemopoietic stem cell transplantation. In: Atkinson K, Champlin R, Ritz J, Fibbe W, Ljungman P, Brenner M, editors. Clinical Bone Marrow and Blood Stem Cell Transplantation. Cambridge: Cambridge University Press; 2004. pp. 194226.

809. Papadopoulos EB, Young JW, Kernan NA, et al. Use of the Tetanus Toxoid, Reduced Dose Diphtheria and Pertussis Vaccine (Tdap) in Allogeneic Transplant (alloHCT) Recipients [Abstract] Blood. 2008;112:2214.

810. Small TN, Rice RD, McCullagh E, et al. Vaccine Efficacy Following Autologous Peripheral Blood Stem Cell Transplant for Lymphoma. Blood. 2007;110:603.

828. LK P, editor. American Academy of Pediatrics. Rabies. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006. pp. 552559.

833. American Academy of Pediatrics. Poliovirus Infections. In: LK P, editor. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006. pp. 542547.

836. American Academy of Pediatrics. Passive Immunization. In: LK P, editor. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006. pp. 5455.

842. American Academy of Pediatrics. Tuberculosis. In: Pickering LK, editor. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006. pp. 678698.

Read more here:
Guidelines for Preventing Infectious Complications among ...

This entry was posted on August 25, 2016 at 1:44 pm and is filed under Stem Cell Complications. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |